Glassman Wealth Services Dexcom Inc Transaction History

Glassman Wealth Services

$585 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$75.49 - $124.16 $3,397 - $5,587	-45 Reduced 6.66%	631 $78,000
Q3 2023 Nov 13, 2023	SELL	$86.06 - $137.93 $5,249 - $8,413	-61 Reduced 8.28%	676 $63,000
Q2 2023 Aug 08, 2023	BUY	$112.47 - $130.98 $787 - $916	7 Added 0.96%	737 $94,000
Q1 2023 May 04, 2023	BUY	$104.0 - $122.92 $4,680 - $5,531	45 Added 6.57%	730 $84,000
Q4 2022 Feb 06, 2023	BUY	$84.98 - $122.67 $2,804 - $4,048	33 Added 5.06%	685 $77,000
Q3 2022 Nov 09, 2022	BUY	$76.35 - $94.18 $9,085 - $11,207	119 Added 22.33%	652 $53,000
Q2 2022 Aug 04, 2022	BUY	$67.99 - $132.89 $27,195 - $53,155	400 Added 300.75%	533 $40,000
Q1 2022 Aug 23, 2022	BUY	$94.08 - $130.2 $940 - $1,302	10 Added 8.13%	133 $68,000
Q1 2022 Apr 14, 2022	BUY	$94.08 - $130.2 $658 - $911	7 Added 6.03%	123 $63,000
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $519 - $651	4 Added 3.57%	116 $62,000
Q3 2021 Nov 10, 2021	BUY	$106.71 - $143.18 $3,628 - $4,868	34 Added 43.59%	112 $61,000
Q2 2021 Aug 04, 2021	SELL	$80.99 - $107.93 $323 - $431	-4 Reduced 4.88%	78 $33,000
Q1 2021 May 05, 2021	BUY	$84.79 - $104.74 $4,069 - $5,027	48 Added 141.18%	82 $29,000
Q4 2020 Feb 04, 2021	SELL	$78.0 - $104.5 $3,666 - $4,911	-47 Reduced 58.02%	34 $13,000
Q3 2020 Nov 09, 2020	BUY	$95.51 - $112.95 $4,011 - $4,743	42 Added 107.69%	81 $33,000
Q2 2020 Aug 06, 2020	BUY	$62.68 - $105.34 $438 - $737	7 Added 21.88%	39 $16,000
Q1 2020 May 12, 2020	BUY	$47.79 - $75.63 $621 - $983	13 Added 68.42%	32 $9,000
Q3 2019 Nov 01, 2019	BUY	$35.53 - $43.8 $106 - $131	3 Added 18.75%	19 $3,000
Q1 2019 May 10, 2019	BUY	$28.07 - $38.18 $449 - $610	16 New	16 $2,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

News

Stay updated on Glassman Wealth Services with notifications on news.

Account